Search Results 51-60 of 16512 for monoclonal antibody

1. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...

2. Rhabdomyosarcoma Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

3. A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas - Mayo Clinic

   A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory ...

4. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

   A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies. Print details.

5. Muromonab-cd3 (intravenous route) - Mayo Clinic

   Muromonab-CD3 is a monoclonal antibody. It is used to reduce the body's natural immunity in patients who receive organ (for example, kidney) transplants ...

6. Small Bowel Cancer Clinical Trials - Mayo Clinic Research

   Monoclonal antibodies, such as pembrolizumab, may ... Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2.

7. Immunization and Antiserum Collection - Antibody Hybridoma Core - Mayo Clinic Research

   The Antibody Hybridoma Core at Mayo Clinic produces monoclonal antibodies using immunized mice housed in a pathogen-free colony.

8. Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13 - Mayo Clinic

   Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13 · Overview · Participation eligibility.

9. Rituximab (intravenous route) - Mayo Clinic

   It helps the immune system destroy cancer cells. Rituximab injection is a monoclonal antibody. Rituximab injection is used together with other medicines (eg, ...

10. Mayo Clinic Proceedings: In the Limelight, May 2021

    ... monoclonal antibody;; The relative lack of awareness by patients and providers of the availability of such therapeutic options; and; The fact that such use of ...